|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 231/14 | (2006.01) |
| A61K 31/415 | (2006.01) |
| (11) | Number of the document | 3828173 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20191747.3 |
| Date of filing the European patent application | 2015-03-09 | |
| (97) | Date of publication of the European application | 2021-06-02 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-31 |
| (46) | Date of publication of the claims translation | 2022-11-10 |
| (30) | Number | Date | Country code |
| 201461949808 P | 2014-03-07 | US | |
| 201461981515 P | 2014-04-18 | US |
| (72) |
KOTIAN, Pravin L. , US
BABU, Yarlagadda S. , US
WU, Minwan , US
CHINTAREDDY, Venkat R , US
KUMAR, Satish V , US
ZHANG, Weihe , US
|
| (73) |
BioCryst Pharmaceuticals, Inc. ,
4505 Emperor Blvd., Durham, NC 27703,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pakeistieji pirazolai kaip žmogaus plazmos kalikreino inhibitoriai |
| SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2026-02-25 | 12 | 289.00 EUR |
| 2027-03-09 |